Page last updated: 2024-08-18

epichlorohydrin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

epichlorohydrin has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukami, K; Haramaki, N; Iida, S; Ikeda, H; Imaizumi, T; Matsuoka, H; Murase, E; Sugano, R; Umei, H	1
Haramaki, N; Ikeda, H; Imaizumi, T; Katoh, A; Matsuoka, H; Sugano, R; Takenaka, K; Yamagishi, S	1

Trials

2 trial(s) available for epichlorohydrin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies. Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:6 Topics: Anticholesteremic Agents; Atherosclerosis; Cell Adhesion; Cholesterol, LDL; Cross-Over Studies; Endothelium, Vascular; Epichlorohydrin; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Imidazoles; Indoles; Lipoproteins, LDL; Male; Middle Aged; Neutrophils; Nitric Oxide Synthase Type III; Phosphorylation; Resins, Synthetic; Serine; Superoxides; Vasodilation	2005
Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase. Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:6 Topics: Adult; Anion Exchange Resins; Blood Platelets; Cholesterol; Cross-Over Studies; Dose-Response Relationship, Drug; Epichlorohydrin; Fatty Acids, Monounsaturated; Female; Fluvastatin; Glutathione; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Imidazoles; Indoles; Male; Middle Aged; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Platelet Aggregation; Polyisoprenyl Phosphates; Prospective Studies; Resins, Synthetic; Treatment Outcome; Triglycerides; Tyrosine	2007

Article

Year

Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies.

Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:6

Topics: Anticholesteremic Agents; Atherosclerosis; Cell Adhesion; Cholesterol, LDL; Cross-Over Studies; Endothelium, Vascular; Epichlorohydrin; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Imidazoles; Indoles; Lipoproteins, LDL; Male; Middle Aged; Neutrophils; Nitric Oxide Synthase Type III; Phosphorylation; Resins, Synthetic; Serine; Superoxides; Vasodilation

2005

Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.

Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:6

Topics: Adult; Anion Exchange Resins; Blood Platelets; Cholesterol; Cross-Over Studies; Dose-Response Relationship, Drug; Epichlorohydrin; Fatty Acids, Monounsaturated; Female; Fluvastatin; Glutathione; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Imidazoles; Indoles; Male; Middle Aged; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Platelet Aggregation; Polyisoprenyl Phosphates; Prospective Studies; Resins, Synthetic; Treatment Outcome; Triglycerides; Tyrosine

2007